Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price & Analysis

–

USD

–(–)

Open

$4.18

Prev. Close

$4.07

High

$4.25

Low

$4.13

Company Profile

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

CEODavid J. Lennon

SectorHealthcare

IndustryBiotechnology

Employees32

IPO DateAug 1, 2017

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address2 Headquarters Plaza

City / State / ZIPMorristown, NJ, 07960

CountryUnited States

Phone551 321 2234

Websitehttps://ir.whitehawktx.com

Whitehawk Therapeutics Inc

Company Profile

Recently from Cashu